Findings from researchers in Canada and Maryland support further development of gene therapy for treating people with fragile X syndrome.| Fragile X News Today
The International Fragile X Premutation Registry, which aims to speed research into the impact of premutations, is enrolling participants.| Fragile X News Today
Category archive page for News.| Fragile X News Today
Steve Bryson is a science writer for Fragile X News Today with a PhD in biochemistry. He covers the latest news and information on a variety of fragile X topics.| Fragile X News Today
Tetra Therapeutics has amended the protocols of two ongoing clinical trials testing zatolmilast to improve access for fragile X patients.| Fragile X News Today